[Home management of bronchopulmonary dysplasia].
Bronchopulmonary dysplasia remains a significant clinical problem associated with the success on survival of neonatal intensive care and has become the common est cause of respiratory insufficiency in infants. The severity of the disease is highly variable from asymptomatic chronic lung disease to patients needing home care with continuous oxygenotherapy and artificial ventilation. Management must try to insure not only appropriate growth and neurodevelopment but also satisfactory well being of the patients. Current medications (aerosoltherapy, diuretics, steroids), rules for oxygenotherapy, follow-up and expected evolution are discussed according to the severity of the disease.
Lombet
J
J
Service Universitaire de Néonatologie, CHR de la Citadelle, Liège, Belgique.
D001993:Bronchodilator Agents / Q000627:therapeutic use; D001997:Bronchopulmonary Dysplasia / Q000150:complications / Q000628:therapy*; D004232:Diuretics / Q000627:therapeutic use; D002149:Energy Intake; D006128:Growth; D006701:Home Nursing; D006801:Humans; D007231:Infant, Newborn; D008991:Monitoring, Physiologic; D010100:Oxygen / Q000627:therapeutic use; D011379:Prognosis; D012119:Respiration
D001993:Bronchodilator Agents; D004232:Diuretics; D010100:Oxygen
Prise en charge à domicile de la dysplasie bronchopulmonaire.